Serum Albumin and Uric Acid Estimation in Ischemic Heart Disease Patients

  • P Kughapriya Government Mohan Kumaramangalam Medical College Hospital, Salem, Tamil Nadu, India,
  • J A Elanchezhian Government Mohan Kumaramangalam Medical College Hospital, Salem, Tamil Nadu,India
Keywords: Hyperuricemia, Hypoalbuminemia, Ischemic heart disease, Oncotic pressure, Semi Auto Analyzer


Aim: The aim of the study was to evaluate serum uric acid and serum albumin levels in ischemic heart disease patients (IHD).
Materials and Methods: Around 60 persons were recruited for the study, with 30 patients diagnosed as IHD and 30 healthy
volunteers. Serum uric acid and serum albumin were estimated using Semi Auto Analyzer. Statistical analysis was performed
using SPSS version 16. The parameters were compared among two groups using independent t-test.
Results: Serum uric acid levels (P = 0.000) were increased significantly in Group II patients compared to those in Group I
controls. There was no significant difference in serum albumin levels among the two groups. Levels of serum albumin in Group I
and Group II are almost similar.
Conclusion: From this study, serum uric acid can be used to assess the prognosis of patients with IHD. Our study showed a
normal serum albumin levels in both the groups, but low serum albumin is associated with high mortality in general.
Clinical significance: Recent studies have provided evidence that uric acid may play a role in the progression of various diseases
including cardiovascular complications. As a result, the measurement of uric acid concentrations is now mandatory for the management
of those disease states. Low serum albumin level causes subclinical fluid overload in IHD patients leading to poor prognosis. Hence,
further studies have to be carried out to assess the association of quality of life in IHD patients and serum albumin levels.

Author Biographies

P Kughapriya, Government Mohan Kumaramangalam Medical College Hospital, Salem, Tamil Nadu, India,

Assistant Professor, Department of Biochemistry,

J A Elanchezhian, Government Mohan Kumaramangalam Medical College Hospital, Salem, Tamil Nadu,India

Associate Professor, Department of General Medicine,


1. Lozano R, Naghavi M, Foreman K. Global and regional mortality from 235
causes of death for 20 age groups in 1990 and 2010: A systematic analysis
for the Global Burden of Disease Study 2010. Lancet 2013;380:2095-128.
2. Roger VL. Epidemiology of myocardial infarction. Med Clin N Am
3. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA.
Hyperuricemia and coronary heart disease: A systematic review and metaanalysis. Arthritis Care Res 2010;62:170-80.
4. Kanbay M, Yilmaz MI, Sonmez A, Solak Y, Saglam M, Cakir E, et al.
Serum uric acid independently predicts cardiovascular events in advanced
nephropathy. Am J Nephrol 2012;36:324-31.
5. Chen W, Roncal-Jimenez C, Lanaspa M, Gerard S, Chonchol M,
Johnson RJ, et al. Uric acid suppresses 1 alpha hydroxylase in vitro and
in vivo. Metabolism 2014;63:150-60
6. Wannamethee SG. Is serum uric acid a risk factor for coronary heart
disease? J Hum Hypertens 1999;13:53-156.
7. Murray RK, Kennelly PJ, Bender DA, Rodwell VW, Botham KM, Weil PA.
Harper’s Illustrated Biochemistry. 29th ed. New York: McGraw-Hill; 2012.
p. 629-33.
8. Parissis JT, Nikolaou M, Mebazaa A, Ikonomidis I, Delgado J, VilasBoas F, et al. Acute pulmonary oedema: Clinical characteristics, prognostic
factors, and in-hospital management. Eur J Heart Fail 2010;12:1193-202.
9. Da Luz PL, Shubin H, Weil MH, Jacobson E, Stein L. Pulmonary edema
related to changes in colloid osmotic and pulmonary artery wedge pressure
in patients after Acute Myocardial Infarction. Circulation 1975;51:350-7.
10. Mayes PA. Lipids of physiological significance. In: Murray RK,
Granner DK, Mayes PA, Rodwell VW, editors. Harper’s Biochemistry.
USA: Prentice Hall International; 1990. p. 134-45.
11. Liu M, Chan CP, Yan BP, Zhang Q, Lam YY, Li RJ, et al. Albumin levels
predict survival in patients with heart failure and preserved ejection fraction.
Eur J Heart Fail 2012;14:39-44.
12. Pasini E, Aquilani R, Gheorghiade M, Dioguardi FS. Malnutrition, muscle
wasting and cachexia in chronic heart failure: The nutritional approach. Ital
Heart J 2003;4:232-5.
13. Iliesiu A, Campeanu A, Dusceac D. Serum uric acid and cardiovascular
disease. Maedica J Clin Med 2010;5:186-92.
14. Alderman M, Aiyer KJ. Uric acid: Role in cardiovascular disease and
effects of losartan. Curr Med Res Opin 2004;20:369-79.
15. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for
cardiovascular disease and death: The Framingham Heart Study. Ann Intern
Med 1999;131:7-13.
16. Kawai T, Ohishi M, Takeya Y, Onishi M, Ito N, Yamamoto K, et al. Serum
uric acid is an independent risk factor for cardiovascular disease and
mortality in hypertensive patients. Hypertens Res 2012;35:1087-92.
17. Nadkar MY, Jain VI. Serum uric acid in acute myocardial infarction.
J Assoc Physicians India 2008;56:759-62.
18. Padma V, Banupriya A. Serum uric acid levels in acute myocardial
infarction. Int J Adv Med 2017;4:1010-3.
19. Filippatos GS, Desai RV, Ahmed MI, Fonarow GC, Love TE, Aban IBet al. Hypoalbuminaemia and incident heart failure in older adults. Eur J
Heart Failure 2011;13:1078-86.
20. Arque`s S, Ambrosi P, Ge´lisse R, Luccioni R, Habib G. Hypoalbuminemia
in elderly patients with acute diastolic heart failure. J Am Coll Cardiol2003;42:712.
21. Horwich TB, Kalantar-Zadeh K, MacLellan RW, Fonarow GC. Albumin
levels predict survival in patients with systolic heart failure. Am Heart J